Earli has an ambitious mission: to force cancer reveal its location at its earliest stages, which makes it quickly treatable. In other words, they aim to make cancer a benign experience. Their science is based on a new method of detecting, localizing and then treating cancer called "Synthetic Biopsies," originally developed by the late Dr. Sam Gambhir at Stanford.

Biotechnology

Earli

Cyriac Roeding

Trupti Patil

Badri Ananthanarayanan

David Suhy

The Scientific Research Team at Earli focuses on advancing the innovative method of "Synthetic Biopsies" to enhance early cancer detection and localization. This multidisciplinary team conducts cutting-edge research in molecular imaging, cell biology, and synthetic biology to develop and refine technologies aimed at making cancer diagnosis and treatment more effective and less invasive. Their work plays a critical role in fulfilling Earli's mission to make cancer a more manageable and benign experience.

Scientific Research Team

About

Team members

Other teams at Earli

Advisory Team

Leadership Team